Key result
Review critically appraises pros and cons of prognostic nomograms for predicting retroperitoneal sarcoma outcomes.
This review provides a critical appraisal of available nomograms for predicting outcomes in retroperitoneal sarcoma patients.
Retroperitoneal sarcoma (RPS) patients can have variable of outcomes after surgery. The chance to recur locally or at distant sites varies according to tumor grade, histologic subtype, and other patient- and tumor-related characteristics. The relative contribution of each prognostic variable on the oncological outcome of RPS patients can be weighted by combining them in prognostic tools such as nomograms. With this review, we critically appraise the available nomograms for RPS patients highlighting pros and cons.
No takes yet. Share an insight, caveat, or question.
Callegaro et al. (2017) conducted a review in Retroperitoneal sarcoma (RPS). Prognostic models (nomograms) was evaluated. This review critically appraises the available prognostic nomograms for retroperitoneal sarcoma patients, highlighting their pros and cons for predicting oncological outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: